Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

Go back to Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
(NASDAQ: CTXR) Delayed: 0.53 -0.01 (1.85%)
Previous Close $0.54    52 Week High $2.50 
Open $0.54    52 Week Low $0.40 
Day High $0.56    P/E N/A 
Day Low $0.53    EPS $0.00 
Volume 125,023